Tokyo, Feb. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060551) titled 'Effect of learning appropriate tourniquet pressure on peripheral vein dilation with a disposable tourniquet' on Feb. 2.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Tokyo Healthcare University
Condition:
Condition - Healthy Adult
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the effect of learning appropriate tourniquet pressure on peripheral vein dilation when using a disposable tourniquet.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - A single educational intervention on appropriate tourniquet pressure will be conducted.
The intervention consists of an explanation of appropriate tourniquet pressure and application techniques, followed by five practice trials in which participants learn to acquire an appropriate tourniquet pressure by sensory perception, such as the feeling of tightening and tactile feedback, while referring to the scale markings as a reference.
The duration of the intervention is approximately 10 minutes, and it is conducted once on a single day during the study period.
Eligibility:
Age-lower limit - 18
years-old
= 70 mmHg.
Key exclusion criteria - Inability to provide informed consent.
Poor physical condition on the day of the experiment (e.g., fever, feeling unwell).
Pain, physical discomfort, or other physical symptoms during the experiment.
Target Size - 34
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 01 Month 05 Day
Date of IRB - 2026 Year 01 Month 05 Day
Anticipated trial start date - 2026 Year 02 Month 02 Day
Last follow-up date - 2026 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069260
Disclaimer: Curated by HT Syndication.